BioCentury
ARTICLE | Company News

Management tracks

April 17, 2017 11:01 PM UTC

Cell therapy company Juno Therapeutics Inc. (NASDAQ:JUNO) named Sunil Agarwal president of R&D. He was CMO of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE).

Non-profit organization The Cancer Research Institute (New York, N.Y.) named Aiman Shalabi CMO. He was VP and head of immuno-oncology global medical affairs at AstraZeneca plc (LSE:AZN; NYSE:AZN). ...